Total Voting Rights
NMC Health
938.40p
16:44 27/04/20
1 November 2024
Bezant Resources PLC
("Bezant" or the "Company")
Total Voting Rights
In conformity with the Disclosure Guidance and Transparency Rules ("DTRs") of the Financial Conduct Authority (the "FCA"), Bezant announces that as at the date of this announcement the Company's total issued share capital consists of 12,304,059,682 ordinary shares of 0.002p each with voting rights ("Ordinary Shares"). The Company does not hold any Ordinary Shares in treasury and accordingly there are no voting rights in respect of any treasury shares.
The abovementioned figure of 12,304,059,682 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Bezant under the FCA's DTRs.
For further information, please contact:
Bezant Resources Plc Colin Bird Executive Chairman |
| |
Beaumont Cornish (Nominated Adviser) |
| |
Novum Securities Limited (Joint Broker) Jon Belliss |
+44 (0) 20 7399 9400 | |
Shard Capital Partners LLP (Joint Broker) Damon Heath |
+44 (0) 20 7186 9952 |
or visit http://www.bezantresources.com
Beaumont Cornish Limited ("Beaumont Cornish") is the Company's Nominated Adviser and is authorised and regulated by the FCA. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other persons for providing protections afforded to customers of Beaumont Cornish nor for advising them in relation to the proposed arrangements described in this announcement or any matter referred to in it.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.